公开(公告)号：US20120226344A1

公开(公告)日：2012-09-06

申请号：US13357150

申请日：2012-01-24

申请人： Junichi SHIROKAZE ,  Yasuharu NOISHIKI

发明人： Junichi SHIROKAZE ,  Yasuharu NOISHIKI

IPC分类号： A61F2/06

CPC分类号： D02G1/0206 ,  A61F2/07 ,  A61L27/00 ,  A61L31/146 ,  D03D1/00 ,  D03D3/02 ,  D03D15/0061 ,  D10B2401/10 ,  D10B2509/06

摘要： Provided is a stent graft that has superior prevention of endoleakage due to being resistant to creasing, and has superior prevention of graft migration as a result of promoting cell infiltration into gaps among microfibers in a dispersed state and forming an integrated structure with the cells in the landing zone of the stent. The stent graft according to the present invention is a stent graft comprising a stent graft fabric that has microfiber bundles consisting essentially of microfilaments having a filament linear density of 0.5 dtex or less, and said microfiber bundles having a total linear density of 10 to 60 dtex/120 to 3000 filaments, for the warp and/or weft, and in which the porosity of the microfiber bundles is 30% to 95%, wherein said stent graft has said stent graft fabric being located in at least 1 cm range from the central end.

摘要翻译： 提供一种支架移植物，其具有优异的防止由于抗皱纹而引起的内漏，并且由于促进细胞渗透到分散状态的微纤维之间的间隙中而形成与该细胞的整体结构的结果，具有优异的移植移植 支架着陆区。 根据本发明的支架移植物是一种支架移植物，其包括具有基本上由细丝线密度为0.5dtex以下的微丝组成的超细纤维束的支架移植物织物，所述超细纤维束的总线密度为10〜60dtex / 120至3000根长丝，用于经纱和/或纬纱，其中微纤维束的孔隙率为30％至95％，其中所述支架移植物具有所述支架移植物织物位于距中心至少1cm的范围内 结束。

公开(公告)号：US20130230636A1

公开(公告)日：2013-09-05

申请号：US13846097

申请日：2013-03-18

申请人： Yasuharu NOISHIKI

发明人： Yasuharu NOISHIKI

IPC分类号： C23C14/48

CPC分类号： C23C14/48 ,  A61F2/06 ,  A61L27/34 ,  A61L27/502 ,  A61L27/507 ,  A61L27/54 ,  A61L27/58 ,  A61L2300/452

摘要： A medical material for in vivo implantation contains a bioabsorbable material containing a softening agent and/or a moisturizing agent and a non-bioabsorbable porous base material, in which the content of a softening agent and/or a moisturizing agent is controlled less than 20 wt %; a method for controlling this content; and a method for producing a medical material for in vivo implantation are provided.

公开(公告)号：US20130230638A1

公开(公告)日：2013-09-05

申请号：US13846073

申请日：2013-03-18

申请人： Yasuharu NOISHIKI

发明人： Yasuharu NOISHIKI

IPC分类号： A61L27/58

CPC分类号： C23C14/48 ,  A61F2/06 ,  A61L27/34 ,  A61L27/502 ,  A61L27/507 ,  A61L27/54 ,  A61L27/58 ,  A61L2300/452

摘要： A medical material for in vivo implantation contains a bioabsorbable material containing a softening agent and/or a moisturizing agent and a non-bioabsorbable porous base material, in which the content of a softening agent and/or a moisturizing agent is controlled less than 20 wt %; a method for controlling this content; and a method for producing a medical material for in vivo implantation are provided.

摘要翻译： 用于体内植入的医疗材料包含含有软化剂和/或保湿剂和非生物可吸收性多孔基材的生物可吸收材料，其中软化剂和/或保湿剂的含量控制在20重量％以下 ％; 一种控制该内容的方法; 提供了用于体内植入的医疗材料的制造方法。

公开(公告)号：US20130230637A1

公开(公告)日：2013-09-05

申请号：US13845985

申请日：2013-03-18

申请人： Yasuharu NOISHIKI

发明人： Yasuharu NOISHIKI

IPC分类号： A61F2/06

CPC分类号： C23C14/48 ,  A61F2/06 ,  A61L27/34 ,  A61L27/502 ,  A61L27/507 ,  A61L27/54 ,  A61L27/58 ,  A61L2300/452

摘要： A medical material for in vivo implantation contains a bioabsorbable material containing a softening agent and/or a moisturizing agent and a non-bioabsorbable porous base material, in which the content of a softening agent and/or a moisturizing agent is controlled less than 20 wt %; a method for controlling this content; and a method for producing a medical material for in vivo implantation are provided.

摘要翻译： 用于体内植入的医疗材料包含含有软化剂和/或保湿剂和非生物可吸收性多孔基材的生物可吸收材料，其中软化剂和/或保湿剂的含量控制在20重量％以下 ％; 一种控制该内容的方法; 提供了用于体内植入的医疗材料的制造方法。